CARE FAKEEH

Dr. Soliman Abdul Kader Fakeeh Hospital Co.

4017StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

1-5

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operations
Operating Cash Flow	453.91M	436.10M	228.63M	-14.63M	254.68M
Free Cash Flow	-7.59M	-81.55M	32.31M	-138.23M	174.63M
Capital Expenditures	-461.50M	-517.65M	-196.32M	-123.60M	-80.05M
Investing & Financing
Investing Cash Flow	-0.62B	-0.70B	1.01B	-0.38B	-0.10B
Financing Cash Flow	0.07B	0.59B	-1.34B	0.52B	-0.15B
Dividends Paid	-0.07B	—	-1.15B	-0.04B	-0.02B
Operating Activities
Operating Cash Flow	453.91M	436.10M	228.63M	-14.63M	254.68M
Net Income	290.18M	287.55M	279.60M	326.32M	334.28M
Change in Accounts Payable	-10.67M	97.60M	43.88M	57.95M	8.61M
Change in Accounts Receivable	-75.13M	-129.53M	-74.86M	-185.29M	-49.56M
Change in Inventory	-17.57M	-15.61M	-31.66M	-6.31M	-3.84M
Change in Other Net Operating Assets	93.54M	66.30M	-81.53M	-386.58M	-249.78M
Change in Working Capital	-9.82M	18.76M	-144.17M	-520.22M	-294.57M
Other Operating Activities	-37.30M	-51.05M	-67.95M	35.97M	41.49M
Provision & Write-off of Bad Debts	24.42M	13.48M	11.35M	20.96M	57.54M
Depreciation & Amortization	178.36M	159.60M	145.82M	109.39M	100.86M
Other Amortization	3.93M	3.28M	3.63M	—	4.26M
Stock-Based Compensation	6.04M	—	—	—	—
Cash Interest Paid	74.04M	124.19M	113.70M	36.61M	15.06M
Asset Writedown & Restructuring Costs	—	—	0.36M	13.07M	9.40M
Investing Activities
Investing Cash Flow	-0.62B	-0.70B	1.01B	-0.38B	-0.10B
Capital Expenditures	-461.50M	-517.65M	-196.32M	-123.60M	-80.05M
Cash Acquisitions	—	—	—	-261.77M	—
Investment in Securities	-99.15M	-195.60M	—	—	—
Other Investing Activities	0.01B	0.02B	1.39B	—	—
Sale (Purchase) of Intangibles	-9.08M	-7.20M	-4.12M	0.46M	-2.28M
Sale (Purchase) of Real Estate	-58.83M	—	-176.08M	—	-19.35M
Sale of Property, Plant & Equipment	2.52M	0.99M	3.53M	0.56M	1.01M
Loss (Gain) From Sale of Assets	-1.91M	4.48M	—	-0.13M	1.41M
Financing Activities
Financing Cash Flow	0.07B	0.59B	-1.34B	0.52B	-0.15B
Common Dividends Paid	-0.07B	—	-1.15B	-0.04B	-0.02B
Issuance of Common Stock	—	1.68B	—	—	—
Long-Term Debt Issued	0.01B	0.11B	1.24B	0.08B	—
Short-Term Debt Issued	82.54M	—	—	504.01M	—
Total Debt Issued	0.10B	0.11B	1.24B	0.58B	—
Long-Term Debt Repaid	-0.04B	-1.06B	-1.40B	-0.05B	-0.13B
Short-Term Debt Repaid	—	-279.00M	-60.02M	—	—
Total Debt Repaid	-0.04B	-1.34B	-1.46B	-0.05B	-0.13B
Net Debt Issued (Repaid)	0.05B	-1.23B	-0.22B	0.54B	-0.13B
Other Financing Activities	84.18M	135.45M	23.41M	20.50M	-0.17M
Free Cash Flow & Returns
Free Cash Flow	-7.59M	-81.55M	32.31M	-138.23M	174.63M
Free Cash Flow Margin	-0.2%	-2.9%	+1.4%	-6.9%	+8.9%
Free Cash Flow Per Share	-0.03	-0.38	0.16	-0.69	1.75
Levered Free Cash Flow	-97.51M	-167.24M	13.93M	18.36M	285.41M
Unlevered Free Cash Flow	-66.98M	-107.45M	90.28M	53.33M	307.15M
Operating Cash Flow Growth	+4.1%	+90.8%	—	—	+7,003.1%
Net Cash Flow	-94.62M	319.49M	-102.47M	125.11M	4.47M

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

1-5

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operations
Operating Cash Flow	453.91M	436.10M	228.63M	-14.63M	254.68M
Free Cash Flow	-7.59M	-81.55M	32.31M	-138.23M	174.63M
Capital Expenditures	-461.50M	-517.65M	-196.32M	-123.60M	-80.05M
Investing & Financing
Investing Cash Flow	-0.62B	-0.70B	1.01B	-0.38B	-0.10B
Financing Cash Flow	0.07B	0.59B	-1.34B	0.52B	-0.15B
Dividends Paid	-0.07B	—	-1.15B	-0.04B	-0.02B
Operating Activities
Operating Cash Flow	453.91M	436.10M	228.63M	-14.63M	254.68M
Net Income	290.18M	287.55M	279.60M	326.32M	334.28M
Change in Accounts Payable	-10.67M	97.60M	43.88M	57.95M	8.61M
Change in Accounts Receivable	-75.13M	-129.53M	-74.86M	-185.29M	-49.56M
Change in Inventory	-17.57M	-15.61M	-31.66M	-6.31M	-3.84M
Change in Other Net Operating Assets	93.54M	66.30M	-81.53M	-386.58M	-249.78M
Change in Working Capital	-9.82M	18.76M	-144.17M	-520.22M	-294.57M
Other Operating Activities	-37.30M	-51.05M	-67.95M	35.97M	41.49M
Provision & Write-off of Bad Debts	24.42M	13.48M	11.35M	20.96M	57.54M
Depreciation & Amortization	178.36M	159.60M	145.82M	109.39M	100.86M
Other Amortization	3.93M	3.28M	3.63M	—	4.26M
Stock-Based Compensation	6.04M	—	—	—	—
Cash Interest Paid	74.04M	124.19M	113.70M	36.61M	15.06M
Asset Writedown & Restructuring Costs	—	—	0.36M	13.07M	9.40M
Investing Activities
Investing Cash Flow	-0.62B	-0.70B	1.01B	-0.38B	-0.10B
Capital Expenditures	-461.50M	-517.65M	-196.32M	-123.60M	-80.05M
Cash Acquisitions	—	—	—	-261.77M	—
Investment in Securities	-99.15M	-195.60M	—	—	—
Other Investing Activities	0.01B	0.02B	1.39B	—	—
Sale (Purchase) of Intangibles	-9.08M	-7.20M	-4.12M	0.46M	-2.28M
Sale (Purchase) of Real Estate	-58.83M	—	-176.08M	—	-19.35M
Sale of Property, Plant & Equipment	2.52M	0.99M	3.53M	0.56M	1.01M
Loss (Gain) From Sale of Assets	-1.91M	4.48M	—	-0.13M	1.41M
Financing Activities
Financing Cash Flow	0.07B	0.59B	-1.34B	0.52B	-0.15B
Common Dividends Paid	-0.07B	—	-1.15B	-0.04B	-0.02B
Issuance of Common Stock	—	1.68B	—	—	—
Long-Term Debt Issued	0.01B	0.11B	1.24B	0.08B	—
Short-Term Debt Issued	82.54M	—	—	504.01M	—
Total Debt Issued	0.10B	0.11B	1.24B	0.58B	—
Long-Term Debt Repaid	-0.04B	-1.06B	-1.40B	-0.05B	-0.13B
Short-Term Debt Repaid	—	-279.00M	-60.02M	—	—
Total Debt Repaid	-0.04B	-1.34B	-1.46B	-0.05B	-0.13B
Net Debt Issued (Repaid)	0.05B	-1.23B	-0.22B	0.54B	-0.13B
Other Financing Activities	84.18M	135.45M	23.41M	20.50M	-0.17M
Free Cash Flow & Returns
Free Cash Flow	-7.59M	-81.55M	32.31M	-138.23M	174.63M
Free Cash Flow Margin	-0.2%	-2.9%	+1.4%	-6.9%	+8.9%
Free Cash Flow Per Share	-0.03	-0.38	0.16	-0.69	1.75
Levered Free Cash Flow	-97.51M	-167.24M	13.93M	18.36M	285.41M
Unlevered Free Cash Flow	-66.98M	-107.45M	90.28M	53.33M	307.15M
Operating Cash Flow Growth	+4.1%	+90.8%	—	—	+7,003.1%
Net Cash Flow	-94.62M	319.49M	-102.47M	125.11M	4.47M